相关实验视频

Updated: Jun 16, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

一个"铁"纳米粒子诱导不可逆转的线粒体损伤,用于抗瘤治疗

Zixu Wang¹, Shanshan Xiang¹, Yihe Qiu¹

¹College of Pharmaceutical Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.

Journal of controlled release : official journal of the Controlled Release Society

|August 17, 2024

概括

这项研究引入了"铁"纳米粒子,通过向线粒体诱导癌细胞死亡. 这些纳米粒子破坏铁代谢并抑制自,导致不可逆转的线粒体损伤和亡.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症生物学癌症生物学

背景情况:

细胞铁对线粒体功能至关重要,但其失调有助于癌症.
现有的铁化疗法通常仅限于辅助作用.
准线粒体铁稳态是一种新的治疗策略.

研究的目的:

开发一种用于向癌细胞死亡的"铁"纳米粒子 (Dp44mT@HTH).
为了研究纳米粒子诱导线粒体破坏和亡的机制.
通过不可逆转的线粒体损伤探索铁耗治疗的潜力.

主要方法:

用氨酸 (HA) 制造DP44mT@HTH纳米颗粒用于CD44受体向.
在实验室中对纳米粒子内部化,溶酶体逃逸和拆卸的评估.
评估DP44mT诱导的线粒体功能障碍和HCQ介导的自抑制.
对ROS触发的药物释放和随后诱导癌细胞死亡的分析.

主要成果:

Dp44mT@HTH纳米颗粒专门针对CD44表达4T1瘤细胞.
纳米颗粒有效释放DP44mT (铁化剂) 和HCQ (自抑制剂) 作为对ROS的反应.
Dp44mT@HTH通过破坏Fe2+稳态和呼吸链来诱导显著的线粒体功能障碍.
铁吸收的联合抑制和自菌体-溶酶体融合导致了不可逆转的线粒体损伤和亡.

结论:

"铁"纳米粒子策略通过有针对性的线粒体破坏有效诱导癌细胞死亡.
抑制自介导的损伤线粒体的去除可以提高铁化疗法的疗效.
这种方法通过利用依赖铁的线粒体通路为抗癌治疗提供了一个有希望的新方向.

关键词:

抗瘤策略抗瘤策略自自是一种自的过程.细胞铁是细胞的铁.铁的化是铁的化.线粒体功能障碍线粒体功能障碍

更多相关视频

Biofunctionalization of Magnetic Nanomaterials

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...